DV
Dividend Vision

BNGO — Bionano Genomics Inc

Bionano Genomics Inc (BNGO)

Total return is -100.0% over the past 8 years, 306.2 points behind SPY at 206.2%. Its deepest 1-year drawdown was 78.5%.

BNGO is an equity stock that provides direct exposure to Bionano Genomics Inc, a life sciences company operating in the genomics sector. As a single-stock holding rather than a diversified fund, it carries no dividend distribution rate or expense ratio typical of ETFs. This instrument appeals primarily to investors seeking concentrated exposure to a specific genomics company rather than those focused on dividend income or broad market diversification.

BNGO key facts

Asset type
Stock
Asset class
Equity
Inception date
08/21/2018
Last close
$1.18
Market cap
$13,196,250
Average volume
84200.0
Beta
1.618
Payout ratio
0.0
Forward P/E
0.0
EPS
$-4.46